Details for Patent: 4,851,229
✉ Email this page to a colleague
Summary for Patent: 4,851,229
| Title: | Composition comprising a therapeutic agent and a modulating agent |
| Abstract: | An osmotic delivery system is disclosed for delivering a useful agent at a controlled and constant rate modulated by a pulsed delivery of the useful agent to an environment of use. |
| Inventor(s): | Paul R. Magruder, Brian Barclay, Patrick S. L. Wong, Felix Theeuwes |
| Assignee: | Alza Corp |
| Application Number: | US07/150,124 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Delivery; Device; |
Drugs Protected by US Patent 4,851,229
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,851,229
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 1251708 | ⤷ Start Trial | |||
| Germany | 3443586 | ⤷ Start Trial | |||
| Spain | 293000 | ⤷ Start Trial | |||
| Spain | 295960 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
